Peter Frederick Morrison, MD | |
49 Spring St, 2nd Floor, Scarborough, ME 04074-8926 | |
(207) 883-1414 | |
(207) 883-1010 |
Full Name | Peter Frederick Morrison |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 23 Years |
Location | 49 Spring St, Scarborough, Maine |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407909344 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0402X | Psychiatry & Neurology - Neurology With Special Qualifications In Child Neurology | MD17828 (Maine) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Maine Medical Center | Portland, ME | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Maine Medical Partners | 9335043967 | 789 |
Mainehealth | 7517860588 | 2067 |
News Archive
According to new research a diet rich with fruit, vegetables and fish can reduce a child's risk of developing asthma and allergies.
Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids may improve mood and reduce negative emotions.
› Verified 7 days ago
Entity Name | Mainehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
According to new research a diet rich with fruit, vegetables and fish can reduce a child's risk of developing asthma and allergies.
Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids may improve mood and reduce negative emotions.
› Verified 7 days ago
Entity Name | Maine Medical Partners |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992719272 PECOS PAC ID: 9335043967 Enrollment ID: O20050901000035 |
News Archive
According to new research a diet rich with fruit, vegetables and fish can reduce a child's risk of developing asthma and allergies.
Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids may improve mood and reduce negative emotions.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Peter Frederick Morrison, MD 301 Us Route 1, Building C, Scarborough, ME 04074-9701 Ph: (207) 396-8600 | Peter Frederick Morrison, MD 49 Spring St, 2nd Floor, Scarborough, ME 04074-8926 Ph: (207) 883-1414 |
News Archive
According to new research a diet rich with fruit, vegetables and fish can reduce a child's risk of developing asthma and allergies.
Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
The human opioid system contributes to the regulation of emotions, pleasure and pain. Opioids are strong analgesics. In addition to effectively relieving pain, external opioids may improve mood and reduce negative emotions.
› Verified 7 days ago
Dr. Jason Alan Helis, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 | |
Dr. Benjamin James Drapcho, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 92 Campus Dr Fl 2, Scarborough, ME 04074 Phone: 207-883-1414 | |
Peter Y. Kang, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7 Oak Hill Ter Ste 218, Scarborough, ME 04074 Phone: 207-303-0022 Fax: 207-303-0023 | |
Dr. Jacob Morgan Stout, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 92 Campus Dr, Scarborough, ME 04074 Phone: 207-662-0111 | |
John R Belden, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Heidi L Henninger, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, 2nd Floor, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1518 | |
Diana Jeanne Goodman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 49 Spring St, Scarborough, ME 04074 Phone: 207-883-1414 Fax: 207-883-1010 |